AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $81,000 | -64.0% | 33 | 0.0% | 0.00% | – |
| Q1 2022 | $225,000 | -88.4% | 33 | -86.2% | 0.00% | – |
| Q4 2021 | $1,939,000 | -97.5% | 240 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $76,653,000 | +26.7% | 7,822 | -12.1% | 0.02% | +28.6% |
| Q2 2021 | $60,519,000 | -24.8% | 8,900 | 0.0% | 0.01% | -39.1% |
| Q1 2021 | $80,452,000 | +35.3% | 8,900 | 0.0% | 0.02% | +35.3% |
| Q4 2020 | $59,449,000 | +32.5% | 8,900 | 0.0% | 0.02% | +30.8% |
| Q3 2020 | $44,854,000 | -37.6% | 8,900 | 0.0% | 0.01% | -31.6% |
| Q2 2020 | $71,910,000 | – | 8,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |